These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24451633)

  • 1. Approaches to Scaffold Hopping.
    Lloyd DG
    Drug Discov Today Technol; 2013 Dec; 10(4):e451-2. PubMed ID: 24451633
    [No Abstract]   [Full Text] [Related]  

  • 2. Expanding the medicinally relevant chemical space with compound libraries.
    López-Vallejo F; Giulianotti MA; Houghten RA; Medina-Franco JL
    Drug Discov Today; 2012 Jul; 17(13-14):718-26. PubMed ID: 22515962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A minimalist fragment approach for the design of natural-product-like synthetic scaffolds.
    Genis D; Kirpichenok M; Kombarov R
    Drug Discov Today; 2012 Nov; 17(21-22):1170-4. PubMed ID: 22659098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.
    Pérot S; Sperandio O; Miteva MA; Camproux AC; Villoutreix BO
    Drug Discov Today; 2010 Aug; 15(15-16):656-67. PubMed ID: 20685398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodiversity of small molecules--a new perspective in screening set selection.
    Petrone PM; Wassermann AM; Lounkine E; Kutchukian P; Simms B; Jenkins J; Selzer P; Glick M
    Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early phase drug discovery: cheminformatics and computational techniques in identifying lead series.
    Duffy BC; Zhu L; Decornez H; Kitchen DB
    Bioorg Med Chem; 2012 Sep; 20(18):5324-42. PubMed ID: 22938785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicinal chemistry inspired fragment-based drug discovery.
    Lanter J; Zhang X; Sui Z
    Methods Enzymol; 2011; 493():421-45. PubMed ID: 21371600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of scaffold-hopping approaches.
    Sun H; Tawa G; Wallqvist A
    Drug Discov Today; 2012 Apr; 17(7-8):310-24. PubMed ID: 22056715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Learning from PAINful lessons.
    Erlanson DA
    J Med Chem; 2015 Mar; 58(5):2088-90. PubMed ID: 25710486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring activity cliffs in medicinal chemistry.
    Stumpfe D; Bajorath J
    J Med Chem; 2012 Apr; 55(7):2932-42. PubMed ID: 22236250
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent developments in de novo design and scaffold hopping.
    Mauser H; Guba W
    Curr Opin Drug Discov Devel; 2008 May; 11(3):365-74. PubMed ID: 18428090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs in action.
    Eggert US; Superti-Furga G
    Nat Chem Biol; 2008 Jan; 4(1):7-11. PubMed ID: 18084271
    [No Abstract]   [Full Text] [Related]  

  • 13. Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2006.
    Dolle RE; Le Bourdonnec B; Goodman AJ; Morales GA; Salvino JM; Zhang W
    J Comb Chem; 2007; 9(6):855-902. PubMed ID: 17877417
    [No Abstract]   [Full Text] [Related]  

  • 14. Fragment-based discovery of JAK-2 inhibitors.
    Antonysamy S; Hirst G; Park F; Sprengeler P; Stappenbeck F; Steensma R; Wilson M; Wong M
    Bioorg Med Chem Lett; 2009 Jan; 19(1):279-82. PubMed ID: 19019674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragment-based drug design - tools, practical approaches, and examples. Preface.
    Kuo LC
    Methods Enzymol; 2011; 493():xxi-xxii. PubMed ID: 21371584
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2007.
    Dolle RE; Le Bourdonnec B; Goodman AJ; Morales GA; Thomas CJ; Zhang W
    J Comb Chem; 2008; 10(6):753-802. PubMed ID: 18991466
    [No Abstract]   [Full Text] [Related]  

  • 17. How well can fragments explore accessed chemical space? A case study from heat shock protein 90.
    Roughley SD; Hubbard RE
    J Med Chem; 2011 Jun; 54(12):3989-4005. PubMed ID: 21561141
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacophore modeling and applications in drug discovery: challenges and recent advances.
    Yang SY
    Drug Discov Today; 2010 Jun; 15(11-12):444-50. PubMed ID: 20362693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecules and their role in effective preclinical target validation.
    Clegg MA; Tomkinson NC; Prinjha RK; Humphreys PG
    Future Med Chem; 2017 Sep; 9(14):1579-1582. PubMed ID: 28828889
    [No Abstract]   [Full Text] [Related]  

  • 20. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.